The Impact of Sub-Cellular Location and Intracellular Neuronal Proteins on Properties of GABAA Receptors
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Most studies of GABA(A) receptor accessory proteins have focused on trafficking, clustering and phosphorylation state of the channel-forming subunits and as a result a number of proteins and mechanisms have been identified that can influence the GABA(A) channel expression and function in the cell plasma membrane. In the light of a growing list of intracellular and transmembrane neuronal proteins shown to affect the fate, function and pharmacology of the GABA(A) receptors in neurons, the concept of what constitutes the native GABA(A) receptor complex may need to be re-examined. It is perhaps more appropriate to consider the associated proteins or some of them to be parts of the receptor channel complex in the capacity of ancillary proteins. Here we highlight some of the effects the intracellular environment has on the GABA-activated channel function and pharmacology. The studies demonstrate the need for co-expression of accessory proteins with the GABA(A) channel-forming subunits in heterologous expression systems in order to obtain the full repertoire of GABA(A) receptors characteristics recorded in the native neuronal environment. Further studies e.g. on gene-modified animal models are needed for most of the accessory proteins to establish their significance in normal physiology and in pathophysiology of neurological and psychiatric diseases. The challenge remains to elucidate the effects that the accessory proteins and processes (e.g. phosphorylation) plus the sub-cellular location have on the "fine-tuning" of the functional and pharmacological properties of the GABA(A) receptor channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
Farrant, M., & Nusser, Z. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1625 · Cited by 2,081 · cited 2×
“In recent years the importance of tonic inhibition in neuronal and neuronal-networks function has become evident [95, 96].”
BackgroundMacdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975 · cited 1×
“In general there is a good qualitative agreement between studies done in expression systems and those done in neurons [3, 5, 12].”
ResultThe interaction between Stargazin and PSD-95 regulates AMPA receptor surface trafficking
Bats, C., Groc, L., & Choquet, D. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.030 · Cited by 590 · cited 2×
“Studies on GABAA, glycine and AMPA receptors further indicate that confinement of receptors at synaptic sites are regulated, at least in part, by postsynaptic mechanisms [23, 113, 115, 117].”
BackgroundTrace fear conditioning involves hippocampal α 5 GABA A receptors
Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528
Surface trafficking of receptors between synaptic and extrasynaptic membranes: and yet they do move!
Triller, A., & Choquet, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.001 · Cited by 285
Jovanovic, J. N., Thomas, P., Kittler, J. T., Smart, T. G., & Moss, S. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3606-03.2004 · Cited by 273
Mechanism of action of benzodiazepines on GABA A receptors
Campo‐Soria, C., Chang, Y., & Weiss, D. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706796 · Cited by 212
Baude, A., Bleasdale, C., Dalezios, Y., Somogyi, P., & Klausberger, T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl117 · Cited by 137
Mihic, S. J., Whiting, P. J., Klein, R. L., Wafford, K. A., & Harris, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)30057-0 · Cited by 110
Brandon, N. J., Jovanovic, J. N., Smart, T. G., & Moss, S. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06353.2002 · Cited by 106 · cited 1×
“RACK1 regulates target specific phosphorylation, PKC [32]”
Cited by
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
GABA is an effective immunomodulatory molecule
Jin, Z., Mendu, S. K., & Birnir, B. (2013) · Amino Acids · doi:10.1007/s00726-011-1193-7 · Cited by 289
“The channels are either located at synapses where they generate phasic currents or outside of synapses where they are termed extrasynaptic channels and generate tonic currents (Birnir and Korpi 2007).”
Self-citationRegulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Self-citationγ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes
Taneera, J., Jin, Z., Jin, Y., Muhammed, S. J., Zhang, E., Lang, S., Salehi, A., Korsgren, O., Renström, E., Groop, L., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2548-7 · Cited by 117
Self-citationGABAergic system in the endocrine pancreas: a new target for diabetes treatment
Wang, Q., Prud'homme, G., & Wan, Y. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s50642 · Cited by 100
Metadata
- Authors
- Birnir, B., & Korpi, E.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-11-01
- Volume
- 13
- Issue
- 31
- Pages
- 3169-3177
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W1979103195
- Cited by
- 44
- References
- 11
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Sub-Cellular Location and Intracellular Neuronal Proteins on Properties of GABAA Receptors. https://app.cochat.ai/papers/10.2174/138161207782341330
- The paper
- Birnir, B., & Korpi, E. (2007). The Impact of Sub-Cellular Location and Intracellular Neuronal Proteins on Properties of GABAA Receptors. Current Pharmaceutical Design. https://doi.org/10.2174/138161207782341330
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.